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ABSTRACT
Fortification is the process of adding nutrients or non-nutrient bioactive components to edible products (e.g., food, food constituents, or
supplements). Fortification can be used to correct or prevent widespread nutrient intake shortfalls and associated deficiencies, to balance the
total nutrient profile of a diet, to restore nutrients lost in processing, or to appeal to consumers looking to supplement their diet. Food fortification
could be considered as a public health strategy to enhance nutrient intakes of a population. Over the past century, fortification has been
effective at reducing the risk of nutrient deficiency diseases such as beriberi, goiter, pellagra, and rickets. However, the world today is very different
from when fortification emerged in the 1920s. Although early fortification programs were designed to eliminate deficiency diseases, current
fortification programs are based on low dietary intakes rather than a diagnosable condition. Moving forward, we must be diligent in our approach to
achieving effective and responsible fortification practices and policies, including responsible marketing of fortified products. Fortification must
be applied prudently, its effects monitored diligently, and the public informed effectively about its benefits through consumer education efforts. Clear
lines of authority for establishing fortification guidelines should be developed and should take into account changing population demographics,
changes in the food supply, and advances in technology. This article is a summary of a symposium presented at the ASN Scientific Sessions and Annual
Meeting at Experimental Biology 2014 on current issues involving fortification focusing primarily on the United States and Canada and
recommendations for the development of responsible fortification practices to ensure their safety and effectiveness. Adv Nutr 2015;6:124–131.
Keywords: dietary intake, dietary supplements, folate, folic acid, vitamin B-9
Introduction
The International Life Sciences Institute (ILSI) North America
Committee on Fortification, in cooperation with the ASN,
sponsored a 2014 Experimental Biology symposium to dis-
cuss the role of fortification in meeting nutrient needs with a
primary emphasis on the United States. This overview sum-
marizes the state of current knowledge regarding dietary
intakes and the possible role of fortification in the future
and concludes with recommendations on responsible, safe,
and effective fortification practices.
In the United States, fortification is the process of adding
nutrients or non-nutrient bioactive components to food
products (e.g., food, food constituents, or supplements).
Fortification may be used as a tool to correct or prevent wide-
spread nutrient inadequacies and, hence, correct associated
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micronutrient deficiencies to balance the total nutrient
profile of diets, to restore nutrients lost in food process-
ing, or to make products more appealing to consumers.
Nutrients may be added to foods, such as with restoration
of nutritional value through enrichment of refined grains
in which nutrients lost during processing (thiamin, niacin,
riboflavin, and iron) are added back (1). In some cases,
foods may also be fortified with nutrients not normally
present, such as the addition of calcium to orange juice.
Although some foods are fortified or enriched under
the umbrella of FDA regulations and provisions, some
foods are fortified with nutrients at the manufacturer’s
discretion.
The FDA established its Food Fortification Policy (2) in
1980. This policy was guided by 6 basic principles: 1) the nu-
trient intake without fortification is below the desirable con-
tent for a significant portion of the population, 2) the food
being fortified is consumed in quantities that would make a
significant contribution to the population’s intake of the nu-
trient, 3) the additional nutrient intake resulting from
fortification is unlikely to create an imbalance of essential nu-
trients, 4) the nutrient added is stable under proper conditions
of storage and use, 5) the nutrient is physiologically available
from the food to which it is being added, and 6) there is rea-
sonable assurance that it will not result in potentially toxic in-
takes. In response to the discussions surrounding increased
interest in fortification, the FDA has stated that decisions rel-
ative to food fortification should be based primarily on clinical
and biochemical data rather than on dietary data alone, as had
been the basis of earlier guidance on fortification (3).
Although the FDA’s fortification policy remains relevant,
the food environment has changed dramatically and essen-
tial nutrient deficiencies are much less common. Therefore,
with the original principles in mind, it is necessary to ex-
plore how nutrient fortification contributes in the context
of current nutrient intakes.
The US Experience with Fortification
Early fortification programs were developed to treat and
prevent readily diagnosed nutrient deficiencies (e.g., beri-
beri, goiter, rickets, and pellagra) that were either epidemic
or occurred in specific population groups. Today, fortifica-
tion programs tend to be based on dietary intakes below rec-
ommendations on the basis of age and sex, as demonstrated
by dietary surveys, rather than attempting to correct a recog-
nized health issue or disease. Selecting a food vehicle for for-
tification and identifying which populations might be at risk
of micronutrient inadequacies are difficult because of the di-
verse food patterns in the United States today.
Once the need for fortification is established, whether
by prevalence of disease because of micronutrient defi-
ciencies or low nutrient intakes, the physiologic bioavaila-
bility of fortified nutrients must be considered both to
ensure safety as well as to support efficacy. Supplements
taken separately from food, for example, may result in a
rapid increase in plasma concentrations of the supple-
mented nutrient, whereas consuming a food fortified with
the same nutrient may have a more gradual effect on blood
concentrations because of the presence of the food matrix.
This has been observed with zinc (4). For other micronutri-
ents, such as folate, changes in serum folate could be higher
in food fortification than through supplementation (5). If
the focus of fortification is the health impact it will have on
the population, both the total additional intake and the qual-
ity of the nutrient or nutrients supplied must be taken into
account, not just the intake of the vehicle (fortified food)
alone.
Fortification was initiated in the United States in 1924,
when iodine was voluntarily added to salt to reduce the in-
cidence of endemic goiter. Over the next few years, the inci-
dence of goiter in regions of the United States, collectively
known as the “goiter belt,” decreased significantly. Among
children in Michigan, the incidence of goiter decreased
from 35% to 2.6% between 1924 and 1935 (6). Although io-
dine fortification of salt is now mandatory in ~120 countries
worldwide, including Canada and Mexico, it remains volun-
tary in the United States, and the FDA does not mandate the
listing of iodine content on food packaging (7). Iodine for-
tification of salt was followed in 1933 by the fortification of
milk with vitamin D to prevent rickets based on the recom-
mendation of the American Medical Association Council on
Foods (8). Milk was chosen as the vehicle for the nutrient
because it is a staple food for children as well as for pregnant
and lactating women and is high in calcium and phosphorus,
2 nutrients required for normal bone development. In 1940,
the Committee on Food and Nutrition (now the Food and
Nutrition Board) recommended the addition of thiamin, ni-
acin, riboflavin, and iron to flour. Bread enrichment was vol-
untary at that time. However, the Enrichment Act of 1942
required that all grain products crossing state lines be en-
riched with thiamin, riboflavin, and iron. In 1996, the Enrich-
ment Act was modified to add folic acid to the list of nutrients
that must be added to all grain products.
Attitudes about fortification and fortification policies
have shifted in the United States over the past few decades.
In the 1970s and 1980s, the FDA’s experience with iron for-
tification signaled a paradigm shift in the way fortification
was viewed. In 1974, the National Academy of Sciences rec-
ommended higher contents of iron fortification, based pri-
marily on dietary intake data. The FDA then revised the
standards for iron fortification on the basis of this recom-
mendation. Iron enrichment resulted in high iron intakes
among young men and concerns about iron toxicity were
raised shortly thereafter. In 1977, the FDA lowered the
iron content standards. The agency expressed concern
about maintaining a diet of natural foods and reiterated
that the focus of enrichment and fortification should be
on the replacement of losses that occur during processing
and the correction of established deficiencies, respectively.
At the same time, manufacturers’ interests shifted from ad-
dressing essential nutrient deficiencies to improving con-
sumers’ diet and health. Fortification was beginning to be
recognized as a balancing act in which inadequacies were
to be addressed while avoiding excessive intakes among
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populations with high intakes of fortified foods. In the
1980s, the FDA fortification policy was guided by the fol-
lowing touchstones:
· Start with a demonstrated need· Consider the unintended consequences· Determine the proper fortification vehicle or vehicles and
technical feasibility issues
· Study the potential impact on intakes/status for all age/sex
groups
· Carry out monitoring postfortification
Although the FDA policy is not a regulation, it continues to
serve “as a uniform set of principles that serve as a model for
the rational addition of nutrients to foods” (2).
Although early fortification programs in the United
States essentially eliminated the deficiency disease in ques-
tion, a more recent fortification mandate addressed a devel-
opmental problem (neural tube defects) that was not as
widespread as goiter or rickets had been. Research demon-
strated that low intakes of folate in women were associated
with an increased risk of neural tube defects (9). On the ba-
sis of these findings, the US Public Health Service recom-
mended in 1992 that food be fortified with folic acid (10).
The target group for folic acid fortification was women of
childbearing age because the critical period for folic acid is
30 d before and 6 wk after conception. Because 50% of preg-
nancies are unplanned, a passive solution of fortification of
commonly consumed foods was recommended (9). Cereal
grains were targeted as the logical vehicle because enrich-
ment standards were already in place. Before fortification,
analyses were performed on simulated folic acid intakes
ranging from 70 to 350 mg/100 g grain, including ready-
to-eat cereals (3). The analyses indicated a 4-fold difference
in folate intake among age groups, and the projected fortifi-
cation further increased intakes among individuals with an
already high intake compared with those with low intakes.
It was likely that available food intake data underestimated
intake, which, in turn, could lead to underestimates of pro-
jected intakes. Concerns were also raised about the risk of
nerve damage among vitamin B-12–deficient persons, but
cofortification with vitamin B-12 was not carried out be-
cause of inadequate data to address potential technological
constraints (9). On the basis of food consumption data
from NHANES (11), the folate content of foods was finalized
at 140 mg/100 g enriched grain. The final amount of folate to
be fortified was an accommodation of both effectiveness and
safety (9).
Postfortification assessment found that between 1995 and
1999, folic acid fortification reduced the prevalence of neural
tube defects by almost one-half, from 16.2 to 8.6 per 10,000
(12, 13). However, neural tube defects still occur, suggesting
that insufficient folate is only one contributing factor. Al-
though predictive modeling suggested that an additional
70–100 mg/d would be added to the diet by fortification,
the actual addition was on the order of 200 mg/d based on
serum folate concentrations. Between 1988 and 2006, serum
concentrations of folate increased dramatically, followed by
a slight decrease (14). This could be due to underreporting
of food intake in dietary surveys, underestimation of the fo-
late content in foods, the common practice of overages by
manufacturers to ensure compliance, an increased use of
folate-containing supplements, or a combination of these.
Dietary folate data still overestimate folate inadequacy
when compared with clinical measures. Based on intake,
the prevalence of inadequacy is ~15–20%; based on clinical
measures, inadequacy virtually disappears (15, 16).
Dietary recommendations for nutrient intakes are in-
tended to be met over time; therefore, the usual dietary in-
take of a nutrient (i.e., the average of intake over the two 1-d
dietary records in NHANES) is necessary to describe the
prevalence of inadequate or excessive nutrient intakes (i.e.,
the tails of the distribution). Individuals with a high intake
of a nutrient before fortification may have slightly higher in-
takes once fortification occurs. Dietary supplements can add
substantially to the nutrient intake of individuals who use
them and can alter the nature and shape of the distribution
of the intake among the population. Approximately one-half
of adults and one-third of children are reported to take sup-
plements (17–20).
However, very little is known about the differences in
micronutrient intakes among children, whether or not
they use dietary supplements. The diets of children (aged
2–18 y) were analyzed from NHANES What We Eat in
America, a nationally representative, cross-sectional sur-
vey. Fortification and enrichment were found to increase
the percentage of children who met the Estimated Average
Requirement (EAR)14 for most micronutrients. Before fo-
late fortification, at least 50% of children aged 2–8 y in the
United States were not achieving the recommended intake.
After fortification, however, almost 10% of children in that
age group exceeded the Tolerable Upper Intake Level (UL)
from foods alone; among children taking supplements,
70% exceeded the UL (21). Exceeding the UL was observed
from food sources alone for several nutrients, including
zinc (17%), copper, folic acid, and vitamin A (3%). The
prevalence of intakes exceeding the UL greatly increased
for the micronutrients when dietary supplement use was
considered: zinc (52%), folic acid (49%), vitamin A (45%),
and copper (18%).
The US experience with folic acid fortification and the
limited data on children’s nutrient intakes point to a need
for caution and careful planning for future fortification pro-
grams, such as that being discussed for vitamin D. For ex-
ample, better information on dose-response trajectories is
needed for the nutrients under consideration. It should
also be well established that those at risk are “reachable”
by food fortification and that unintended consequences as-
sociated with high levels of consumption among some por-
tions of the population, especially children, are unlikely.
Better indicators of a public health need for fortification
should be identified.
14 Abbreviations used: DV, Daily Value; EAR, Estimated Average Requirement; UL, Tolerable
Upper Intake Level.
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Global Issues of Fortification
Elsewhere in the world, particularly in low- and middle-
income countries, there are a number of fortification pro-
grams that highlight the enormous benefits of judicious
fortification, as well as potential unforeseen consequences,
including not reaching target populations, overconsumption
of nutrients in groups outside the target population, and
monitoring additional intakes and nutritional status associ-
ated with consumption of fortified foods.
Challenges described in the following examples, such as
choosing appropriate fortification vehicles, reaching target
populations, avoiding overconsumption in nontarget groups,
andmonitoring nutritional status, are relevant to all countries
because they occur everywhere there is an attempt to fortify
foods to optimize intakes and nutritional status. The WHO
issued guidance for the fortification of maize and wheat flour
in 2009 based not on the distribution of intake across differ-
ent segments of the population but on national per capita in-
takes and assuming that no other source provided the referred
micronutrients (22). However, the recommendations pointed
out the following: “These estimated contents consider only
wheat flour as the main fortification vehicle in a public health
program. If other mass-fortification programs with other
food vehicles are implemented effectively, these suggested for-
tification contents need to be adjusted downward as needed.”
This qualification has not been consistently heeded; and
many times, micronutrient contents do not fit the nutritional
necessities of the populations. For example, in Guatemala,
vitamin A has been added to sugar since 1974 (23); and al-
though the current serum concentrations of retinol in chil-
dren and women in the poorest part of the country are the
same as in the United States (24), the Guatemalan govern-
ment still supplies additional vitamin A in the form of sup-
plements every 6 mo to the children of Guatemala and
micronutrient powders also include this vitamin. It is esti-
mated that only a very few of the poorest families do not
reach adequate vitamin A intake (25). Although other forti-
fication vehicles could be considered to deliver vitamin A
(26), sugar remains the most cost-efficient for Central
America.
Once fortification is implemented, there is often reluc-
tance on the part of policy makers to reduce the content of
the nutrient being fortified, even in the face of evidence
that higher doses are not needed to demonstrate benefit.
Folic acid fortification of grain products is well established
as a means to reduce the incidence of neural tube defects
(27). In Chile, the consumption of wheat flour is ~200 g/d;
thus, fortification with folic acid was targeted at 200 mg fo-
late/100 g flour to deliver 400 mg folic acid. Because the for-
tification of wheat flour has been effective for reducing the
prevalence of neural tube defects in Chile, there is little sup-
port for reducing the level of folic acid fortification despite
the very high additional intake of folic acid for the overall
population. There is concern that population subgroups
are at risk of consuming usual intakes above the UL. A pre-
dictive analysis performed in the Dominican Republic to
identify the most effective food vehicles to supply nutrients
that were insufficient highlighted the importance of the
WHO’s statement about multiple fortification (28). Maize
flour, wheat flour, and rice were considered. The results showed
that 85% of the population was not eating maize flour, indicat-
ing that maize flour would not be an effective vehicle for forti-
fication. Wheat flour consumption was found to be one-half
that of the United States. Rice is a staple of the Dominican
diet and is consumed by the majority of the population.
Thus, the fortification of rice would have a large impact on nu-
trient intakes in the Dominican Republic. However, the situa-
tion is different in Mexico, where implementing a combination
of wheat flour and maize flour was determined to have the best
potential outcome by covering different segments of the popu-
lation simultaneously while minimizing the risk of overcon-
sumption by using lower contents of the micronutrients in
both flours than by formulating each separately (29).
In Jordan, fortified wheat flour delivers sufficient iron to
improve iron status in children, but the amount of iron de-
livered to women is thought to be inadequate. As a result of
iron fortification, iron deficiency anemia decreased signifi-
cantly in children from 26% to 13.7%, but no improvement
was observed in women (30). In addition, the Middle East
population is known for a high consumption of tea, which
reduces the availability of the iron. Conversely, the vitamin
A provided via wheat flour fortification in Jordan is thought
to be inadequate for children but sufficient for women (31).
The use of more than one fortification vehicle for a di-
verse population may prove to be the most effective way
to reach the largest number of people and present the lowest
risk of excessive intakes (29). Several countries applied a
similar strategy to determine the maximum allowable nutri-
ent intake from fortification and to avoid exceeding the safe
upper limits that have been established (32–34). It is impor-
tant to approximate the magnitude of the nutritional inad-
equacy of the population (nutrient gap) and the combined
use of food vehicles by using the average estimated intake
for a specific population (29). The supply of fortified nutri-
ents could be proportional to energy intake, taking into ac-
count both minimum and maximum values that will be
fortified in the diet (fortifiable food energy) (29).
Technological Issues with Use of Nanomaterials
for Fortification
Because of organoleptic issues, not all micronutrients that
fall short of recommended contents (e.g., magnesium and
potassium) are suitable for fortification. This presents tech-
nical opportunities that should be investigated, including
the following: safety and efficacy of nanotechnology for for-
tification; overcoming organoleptic problems posed by some
fortificants such as iron, fiber, and potassium; establishing a
better understanding of bioavailability; and overcoming the
degradation of certain fortificants such as vitamins B-12 and
C (35). Theoretically, nanotechnology is a way to deliver nu-
trients in the needed amounts to the surface of specific tis-
sues. The human body has evolved in an environment of
nanomaterials (36). Formerly referred to as colloids or
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colloidal suspensions, there are a variety of biologically use-
ful nanomaterials [e.g., iron sulfur clusters in enzymes such
as aconitase (37), as the by-product of low-temperature
combustion of organic materials such as wood (38), and vol-
canic eruptions (39)]. Therefore, engineered nanomaterials
do not pose a novel “size-challenge” to humans and animals
but may present new morphologies and chemistries as a by-
product of engineered properties that confer new physical-
chemical-mechanical functions.
Nanomaterials are currently used for a wide range of ap-
plications, including the following: nanosized powders to in-
crease the absorption of nutrients; nanoencapsulation of
nutraceuticals for better absorption, improved stability, or
targeted delivery; and nanochelates (coiled nanoparticles)
to deliver nutrients more efficiently without affecting the
color or taste of food. However, safety is a primary concern
with the use of nanotechnology and must first be considered
before efficacy can be addressed. Factors that make nanoma-
terials potentially toxic include the following:
· High aspect ratio: although able to envelope long, thin nano-
structures, macrophages are unable to move them to the proxi-
mal lymphatic node to clear them from lung via the mucociliary
escalator (40, 41).
· Bio-persistence: nanomaterials that move with the distribution
of water or lipid can reside permanently somewhere in the
body. It cannot be predicted where the permanent material
will occupy biological space. The more permanent the nano-
material, the more likely it is to have an interaction in the
body—whether beneficial or adverse (41).
· Reactive surfaces: some are capable of producing reactive oxy-
gen species, increasing potential toxicity (42–44).
· Composition and stability: nanomaterials are capable of de-
livering a super physiologic concentration of materials to an
extremely small space, no longer benefiting from the principle
of volume distribution and thus increasing potential toxicity
(45, 46).
It is well understood that use of nanomaterial-containing
fortificants effectively changes the pharmacokinetics of the for-
tificant itself. Dose metrics of the materials are complex: as the
material becomes smaller, the surface area increases exponen-
tially and therefore so does the probability that the nanomate-
rial will interact with something within the biological space
(41). It is therefore critical to understand the potential for alter-
ations in pharmacodynamics of nutrients, especially those that
are either poorly absorbed or rapidly excreted after gastrointes-
tinal uptake. Similarly, the particulate nature of many nano-
technologies could result in particulate accumulation in the
reticuloendothelial system, resulting in malfunctioning of the
innate immune system. The longer-term health consequences
of engineered materials at the nanometer scale are poorly un-
derstood. A complete understanding of the consequences of
subacute and chronic exposures to engineered nanomaterials
will need to be acquired before they can be used widely to
add fortificants to foods. The development of clear lines of au-
thority for supervising fortification processes in industry, and
regulating and monitoring their use effectively in government,
must accompany advances in these technologies (47, 48).
Risks vs. Benefits of Fortification
Although there is risk in not obtaining adequate nutrients in
the diet, there is also concern about whether individuals are
consuming nutrients in excess. For some nutrients (e.g., zinc
and copper), the window of safety between the values of
EAR and UL for what represents an adequate intake vs. an
excessive intake is relatively small, the difference being a fac-
tor of 4.
Currently, in Canada, discretionary fortification is occur-
ring through Temporary Marketing Authorizations, with the
nutrient additions permitted at contents well in excess of
EARs for many B vitamins (49). A cursory look at the labels
of novel beverages sold in a local supermarket revealed en-
ergy drinks providing as much as 6 times the EAR for vita-
min B-12 and 3 times the EAR for riboflavin, for example,
despite there being no evidence of inadequacy for young
men (50), who appear to be the target audience for many
of these products. Although single high doses of vitamin
B-12 or riboflavin easily exceed human transport capacity,
rendering these vitamins fairly safe, such nutrient additions
are a marked departure from fortification programs de-
signed to address demonstrated problems of nutrient insuf-
ficiency in populations.
Over the past decade, discussions around Daily Values
(DVs) have centered on how they should be developed
and whether changing the DVs would result in changes in
the nutrient concentration in foods. However, much of dis-
cretionary fortification seems to be disconnected from the
conventional view of the DVs listed on nutrient food labels
and regulated language concerning nutrient content claims
or diet-related claims, suggesting that discretionary fortifica-
tion may be insensitive to changes in DVs. There is little ev-
idence that usual intakes at contents in excess of nutrient
requirements are of benefit. Without evidence of benefit,
the question then becomes whether discretionary fortifica-
tion practices can result in harm or wasteful inefficiency
in the food supply. There is a need to better identify the nu-
tritional status of individuals with respect to conditions of
marginal deficiencies (e.g., for vitamin D) to fully under-
stand the potential effects of discretionary fortification.
Despite ULs having been defined for many nutrients, the
consequences of chronically high intakes from fortified
foods and/or supplements is not known. Moreover, the con-
sumption of fortified foods and supplements is correlated;
people with high intakes of fortified food tend to also use
supplements (51). The consumption of fortified foods re-
sults in a higher probability of nutrient intakes near or above
the UL as does the intake of supplements (21, 52–55). Ex-
panded fortification can be expected to affect the upper tails
of intake distributions the most. Whether discretionary for-
tification is beneficial depends on which foods manufac-
turers fortify, which nutrients are chosen as fortificants,
how much of the fortificant is added, and what portion of
the population consumes the fortified products.
Individual differences can affect the outcome of fortifica-
tion. Numerous gene polymorphisms can alter the digestion,
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absorption, and metabolic responses of individuals to certain
nutrients (56). Fortification with folic acid was initiated in
part because of the identification of a high prevalence of pol-
ymorphisms in several folate-dependent genes involved with
single-carbon metabolism. It is now recognized that some of
these polymorphisms can significantly alter folate require-
ments among pregnant women (57). Another emerging
area of interest that could influence the outcome of fortifica-
tion is the composition of the gut microbiome. The size and
diversity of the gut microbiome within specific populations
can be influenced by an individual’s diet, which could, in
turn, affect absorption of certain nutrients (58–60).
Even less is known and understood about the potential
health impact of fortification with non-nutrient bioactive
food components. Flavanols can serve as an example of a
non-nutrient bioactive for which research has suggested
health benefits. Numerous investigators have reported in-
verse associations between the consumption of flavonoid-
rich diets and the risk of cardiovascular disease, and there
is evidence that one family of flavonoids (flavan-3-ols) is
particularly of value with respect to vascular health (61–64).
Complicating the issue of potential dietary recommenda-
tions for flavanols is the fact that the bioavailability and bi-
ological activities of the 4 flavan-3-ol isomers can show
considerable variability (65). This is currently an issue be-
cause the flavanol content of most foods is not provided
with respect to the specific isomers that are present. A further
complication is that food processing can result in changes in
the flavanol stereoisomers that are present in a food or bever-
age. For example, heating tea at a high temperature can alter
the flavanol stereoisomer profile that is present in the final
product (66).
Consistent with the epidemiology, improved vascular
health was reported in several intervention trials in which
subjects were given flavanol-rich foods or beverages (62,
67, 68). The improvements in vascular health were attrib-
uted to a number of factors including flavanol-induced
changes in the immune system, flavanol-induced reductions
in platelet reactivity, and flavanol-induced improvements in
vascular reactivity and vascular tissue repair. Importantly,
the majority of intervention studies with flavanols were con-
ducted in individuals with varying degrees of health compli-
cations (e.g., hypertension, diabetes, cardiovascular disease,
and smoking); additional studies on the effects of flavanol
supplementation in “healthy” individuals are needed before
recommendations for diet flavanol fortification. Although
the results of the supplementation trials have been encour-
aging, it must be noted that the amounts of flavanols that
have been used in most trials exceed what the majority of
the population currently consumes (69). This raises questions
regarding what, if any, potential safety risks exist. Because
higher-than-average intakes may be needed to demonstrate
benefit, potential risk of some segments of the population
could exist. To address this possibility, supplementation trials
are needed that evaluate the safety of flavanols in amounts
that exceed what has been reported to be efficacious in the
clinical trials reported to date.
In addition to studies of the effects of flavanols in
“healthy people,” a better characterization of the flavanol
status of the general population is needed. However, sensi-
tive biomarkers to identify an individual’s status with respect
to the individual flavanols have yet to be identified (70, 71).
Functional biomarkers such as flow-mediated dilation,
arterial stiffness, and platelet reactivity, which have been
used by the European Food Safety Authority as a basis for
flavanol health claims, could be considered in the future
(72, 73).
Summary
Fortification is a tool that has been used successfully to
correct nutrient inadequacies and their associated defi-
ciencies. This is the classic case of mandatory fortification
of staple foods. Interest in fortification has shifted from
prevention of deficiencies to improving health. However,
it is not known whether discretionary fortification im-
proves health, and its long-term effects remain unknown.
Fortification adds to the nutrient intakes of nearly every-
one in a population.
In some countries, even basic information on existing di-
etary intakes is lacking. This is confounded by the nutrients
for which nutrient requirements have not been clearly eluci-
dated for given age group and sex. Accurately assessing in-
takes of fortification vehicles is needed to assess the dietary
impact of any fortification program.
Because the need for and the effectiveness of fortification
varies by age, sex, life stage, and genetic profile, groups that
are at high risk of inadequacy and/or excess deserve special
attention in all countries. It is evident that a greater under-
standing of how food intake influences biomarker concen-
trations is critical so that more appropriate vehicles for
food fortification can be identified and better advice given
to those who wish to pursue this strategy. Identifying and us-
ing biomarkers will be essential for identifying who is at risk.
Furthermore, the foods to fortify as well as the micronu-
trient contents must be chosen carefully, to identify the
most appropriate vehicles for food fortification as well as
target the population at risk of inadequacy without creating
excessive intakes for other subgroups of the population. For-
tification must be applied thoughtfully, its effects monitored
diligently, and the public informed effectively about its role
in dietary intakes through labeling and other sources of con-
sumer education. For research purposes, databases must be
constantly updated to reflect the rapidly evolving market-
place, so that the contribution of both added and intrinsic
micronutrients accurately estimates population intakes.
Future Directions
· There is a need to engage stakeholders to understand the im-
portance of more comprehensive and up-to-date databases on
food and nutrient intakes, and biomarkers associated with nu-
tritional status.
· Optimal discretionary fortification requires high-quality
monitoring, which will require surveys designed to enable
subgroup analysis differentiating consumption behaviors
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(supplements/fortificants) across all age/sex groups, especially
those who are more likely to be exposed to both fortified foods
and supplements.
· There is a need for better tracking/reporting systems to look
for potential adverse effects of excessive nutrient exposures.
· Research is needed to elucidate the potential health conse-
quences of chronically high nutrient intakes that are now pos-
sible from fortificants and supplements.
· Very little is known about the long-term stability of nanoma-
terials as fortificants, how to quantify them in food, or how
they interact with the gut and the greater immune system.
More research is needed.
· When discussing the issue of non-nutritive fortificants in
foods, risk factors such as antinutritional effects, drug interac-
tions, genotoxicity, and possible developmental effects must be
considered. Safety thresholds must be established, the mecha-
nisms of action better understood, and biomarkers identified
before fortifying foods with these compounds.
· Because of the changes that can occur as a result of food pro-
cessing, specific isomers of non-nutritive compounds must be
identified and measured to make it possible to understand the
link between consumption and health outcomes.
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